Virtus ETF Advisers LLC Selecta Biosciences Inc Transaction History

Virtus ETF Advisers LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.67 - $1.4 $32,986 - $68,927	-49,234 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.23 - $3.31 $3,580 - $9,635	-2,911 Reduced 5.58%	49,234 $61,000
Q4 2021 Feb 14, 2022	BUY	$2.89 - $4.43 $28,067 - $43,024	9,712 Added 22.89%	52,145 $170,000
Q3 2021 Nov 15, 2021	SELL	$3.36 - $4.62 $7,442 - $10,233	-2,215 Reduced 4.96%	42,433 $177,000
Q2 2021 Aug 10, 2021	SELL	$2.82 - $5.01 $142,920 - $253,911	-50,681 Reduced 53.16%	44,648 $187,000
Q1 2021 May 17, 2021	BUY	$2.92 - $5.07 $4,888 - $8,487	1,674 Added 1.79%	95,329 $431,000
Q4 2020 Feb 12, 2021	SELL	$1.64 - $3.42 $35,032 - $73,054	-21,361 Reduced 18.57%	93,655 $284,000
Q3 2020 Nov 13, 2020	SELL	$2.18 - $2.84 $34,182 - $44,531	-15,680 Reduced 12.0%	115,016 $285,000
Q2 2020 Aug 05, 2020	BUY	$1.83 - $4.06 $239,173 - $530,625	130,696 New	130,696 $371,000
Q4 2018 Feb 05, 2019	SELL	$2.66 - $15.93 $102,298 - $612,635	-38,458 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$12.07 - $16.0 $340,893 - $451,888	-28,243 Reduced 42.34%	38,458 $598,000
Q2 2018 Aug 10, 2018	BUY	$9.36 - $13.25 $624,321 - $883,788	66,701 New	66,701 $884,000

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.